For: | Zhang SS, Hu WY, Li YJ, Yu J, Sang S, Alsalman ZM, Xie DQ. Lipoprotein (a) variability is associated with mean follow-up C-reactive protein in patients with coronary artery disease following percutaneous coronary intervention. World J Clin Cases 2022; 10(35): 12909-12919 [PMID: 36569022 DOI: 10.12998/wjcc.v10.i35.12909] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i35/12909.htm |
Number | Citing Articles |
1 |
Maria G. Matta, Laura Schreier, Augusto Lavalle-Cobo, Sebastian Garcia-Zamora, Agustina Ferraresi, Angeles Madsen, Sofia Bellini, Guadalupe Ramos, Paula Roubicek, Pablo Corral. Temporal variability of Lp(a) in clinically stable patients: Implications for cardiovascular risk assessment. Medicina Clínica (English Edition) 2024; 163(9): 436 doi: 10.1016/j.medcle.2024.05.018
|
2 |
Hyung Joon Joo, Seung Gyu Yun, Jae Hyoung Park, Soon Jun Hong, Cheol Woong Yu, Seung Yong Shin, Eung Ju Kim. Predictors of lipoprotein(a) variability in clinical practice and their impact on cardiovascular risk. Lipids in Health and Disease 2025; 24(1) doi: 10.1186/s12944-025-02666-8
|
3 |
Maria G. Matta, Laura Schreier, Augusto Lavalle-Cobo, Sebastian Garcia-Zamora, Agustina Ferraresi, Angeles Madsen, Sofia Bellini, Guadalupe Ramos, Paula Roubicek, Pablo Corral. Temporal variability of Lp(a) in clinically stable patients: Implications for cardiovascular risk assessment. Medicina Clínica 2024; 163(9): 436 doi: 10.1016/j.medcli.2024.05.023
|
4 |
Xu Tian, Nan Zhang, Gary Tse, Guangping Li, Yihong Sun, Tong Liu, Maciej Banach. Association between lipoprotein(a) and premature atherosclerotic cardiovascular disease: a systematic review and meta-analysis. European Heart Journal Open 2024; 4(3) doi: 10.1093/ehjopen/oeae031
|